{"id":"https://openalex.org/W2568039121","doi":"https://doi.org/10.1182/blood.v110.11.1151.1151","title":"ReFacto AF Is Effective and Safe in Previously Treated Patients with Severe Hemophilia A: Final Results of a Pivotal Phase III Study.","display_name":"ReFacto AF Is Effective and Safe in Previously Treated Patients with Severe Hemophilia A: Final Results of a Pivotal Phase III Study.","publication_year":2007,"publication_date":"2007-11-16","ids":{"openalex":"https://openalex.org/W2568039121","doi":"https://doi.org/10.1182/blood.v110.11.1151.1151","mag":"2568039121"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v110.11.1151.1151","doi":"https://doi.org/10.1182/blood.v110.11.1151.1151","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.1151.1151","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018280451","display_name":"Michael Recht","orcid":"https://orcid.org/0000-0002-2805-1016","observed_orcids":["https://orcid.org/0000-0002-2805-1016"]},"institutions":[{"id":"https://openalex.org/I4210124153","display_name":"Phoenix Children's Hospital","ror":"https://ror.org/03ae6qy41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124153"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Recht","raw_affiliation_strings":["Center for Cancer & Blood Disorders, Phoenix Children\u2019s Hospital, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer & Blood Disorders, Phoenix Children\u2019s Hospital, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210124153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076921639","display_name":"L\u00e1szl\u00f3 Nemes","orcid":"https://orcid.org/0000-0002-3359-236X","observed_orcids":["https://orcid.org/0000-0002-3359-236X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Laszlo Nemes","raw_affiliation_strings":["National Haemophilia Center, National Medical Centre, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Haemophilia Center, National Medical Centre, Budapest, Hungary","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018273953","display_name":"Amanda C. O\u2019Brien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Amanda C. O\u2019Brien","raw_affiliation_strings":["National Haemophilia Center, National Medical Centre, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Haemophilia Center, National Medical Centre, Budapest, Hungary","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085388496","display_name":"Chandrasekhar Udata","orcid":"https://orcid.org/0009-0003-7938-5432","observed_orcids":["https://orcid.org/0009-0003-7938-5432"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chandrasekhar Udata","raw_affiliation_strings":["Cardiovascular Pharma, Research & Dev, Wyeth Research, Collegeville, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Pharma, Research & Dev, Wyeth Research, Collegeville, PA, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Roth","raw_affiliation_strings":["CR&D, Wyeth Research, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CR&D, Wyeth Research, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059475095","display_name":"Steven Arkin","orcid":"https://orcid.org/0000-0001-6922-4246","observed_orcids":["https://orcid.org/0000-0001-6922-4246"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Arkin","raw_affiliation_strings":["CR&D, Wyeth Research, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CR&D, Wyeth Research, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018273953","https://openalex.org/A5018280451","https://openalex.org/A5076921639","https://openalex.org/A5085388496"],"corresponding_institution_ids":["https://openalex.org/I4210124153","https://openalex.org/I4403928396"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4079,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.69162309,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"110","issue":"11","first_page":"1151","last_page":"1151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-factor-viii","display_name":"recombinant factor VIII","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9480000138282776},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.8880000114440918},{"id":"https://openalex.org/keywords/advate","display_name":"Advate","score":0.574999988079071},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9729999899864197},{"id":"https://openalex.org/keywords/on-demand-treatment","display_name":"on-demand treatment","score":0.8330000042915344},{"id":"https://openalex.org/keywords/annualized-bleed-rate","display_name":"annualized bleed rate","score":0.8740000128746033},{"id":"https://openalex.org/keywords/factor-viii-replacement-therapy","display_name":"factor VIII replacement therapy","score":0.3709999918937683},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.5860000252723694},{"id":"https://openalex.org/keywords/one-stage-clotting-assay","display_name":"one-stage clotting assay","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.8728967905044556},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7232943773269653},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6623303890228271},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6271768808364868},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5735424160957336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4647976756095886},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4303808808326721},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.41234782338142395},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3447471261024475},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33581310510635376},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1459026038646698},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08698946237564087},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v110.11.1151.1151","doi":"https://doi.org/10.1182/blood.v110.11.1151.1151","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.1151.1151","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2554706300","https://openalex.org/W2130950376","https://openalex.org/W2094684871","https://openalex.org/W2558013362","https://openalex.org/W2000958165","https://openalex.org/W1969865403","https://openalex.org/W2020338307","https://openalex.org/W2570373061","https://openalex.org/W2242740080","https://openalex.org/W3166314236"],"abstract_inverted_index":{"Abstract":[0],"ReFacto":[1,50,78,117,154,168,220,227,262,336,407,410,424],"AF":[2,51,79,118,155,169,228,263,408,411,425],"(Albumin-Free":[3],"Cell":[4],"Culture":[5],"Process)":[6],"is":[7,412,427,436],"a":[8,20,28,85,123,211,309,363,390],"BDDrFVIII":[9],"manufactured":[10],"using":[11,19,102],"an":[12,40],"albumin-free":[13],"cell":[14,397],"culture":[15],"process":[16],"and":[17,114,170,191,194,213,224,236,244,289,315,337,354,366,423,441,454],"purified":[18],"chemically":[21],"synthesized":[22],"peptide":[23,402],"affinity":[24,403],"ligand":[25,404],"instead":[26],"of":[27,49,77,116,125,138,167,180,204,291,301,312,335,342,432,443,452],"murine":[29],"monoclonal":[30],"antibody.":[31],"A":[32,149,299],"virus-retaining":[33],"filtration":[34],"step":[35],"has":[36,52],"been":[37,53],"included":[38,131],"as":[39,65,147],"additional":[41],"safety":[42,447,459],"precaution":[43],"during":[44,135],"manufacture.":[45],"The":[46,73,178,323,373,434],"potency":[47],"assignment":[48],"aligned":[54],"to":[55,60,287,395,400,415],"the":[56,103,109,132,159,201,245,254,276,332,343,387,401,439,455],"one-stage":[57,110,419],"clotting":[58,111],"assay,":[59],"permit":[61],"routine":[62,141,267,274,360],"clinical":[63],"monitoring,":[64],"for":[66,184,226,376,381,406],"other":[67,338],"rFVIII":[68,339],"products,":[69],"without":[70],"specialized":[71],"standards.":[72],"pharmacokinetic":[74],"(PK)":[75],"profile":[76,250,328,334,457],"vs.":[80],"Advate":[81,171,416],"was":[82,119,156,172,251,270,281,329,368],"assessed":[83,121],"in":[84,91,122,158,386,438,460],"randomized":[86],"double":[87],"blind":[88],"crossover":[89],"fashion,":[90],"30":[92,176],"previously":[93],"treated":[94,306],"patients":[95,294,345],"(PTPs)":[96],"(\u2265":[97],"12":[98],"years;":[99],"FVIII:C":[100],"\u22641%)":[101],"standard":[104],"bioequivalence":[105,202],"approach":[106],"based":[107,417],"upon":[108],"assay.":[112],"Safety":[113],"efficacy":[115],"also":[120],"total":[124,300],"94":[126,255,292,344],"PTPs":[127,461],"(FVIII":[128],"\u22642%),":[129],"which":[130],"PK":[133,151,160,217,249,426],"subjects,":[134],"6":[136,163,214,246,430],"months":[137,431],"open":[139],"label":[140],"prophylaxis":[142,268],"supplemented":[143],"with":[144,153,219,308,318,331,462],"on-demand":[145,307],"treatment":[146,442],"necessary.":[148],"follow-up":[150,216,248,371],"assessment":[152,218],"performed":[157],"subjects":[161,209],"after":[162],"months.":[164],"Pharmacokinetic":[165],"equivalence":[166],"demonstrated":[173],"(n":[174],"=":[175],"subjects).":[177],"ratios":[179],"geometric":[181],"least-square":[182],"means":[183],"K-value,":[185],"AUCt,":[186],"AUC\u221e":[187],"were":[188,199,229,305,379],"100%,":[189],"89.8%,":[190],"88.0%,":[192],"respectively,":[193],"associated":[195],"90%":[196],"confidence":[197],"intervals":[198],"within":[200],"window":[203],"80%\u2013125%.":[205],"Twenty":[206],"five":[207],"(25)":[208],"had":[210,346,389],"baseline":[212,243],"month":[215,247],"AF.":[221],"Mean":[222],"K-value":[223],"t1/2":[225],"2.23":[230],"(\u00b1":[231,238],"0.39)":[232],"IU/dL":[233],"per":[234],"IU/kg":[235],"11.8":[237],"5.1)":[239],"hours,":[240],"respectively":[241],"at":[242,259],"unchanged.":[252],"Of":[253],"patients,":[256],"89":[257],"accrued":[258],"least":[260],"50":[261],"exposure":[264],"days.":[265],"Median":[266],"dose":[269,311],"30.2":[271],"IU/kg.":[272],"During":[273],"prophylaxis,":[275],"median":[277,310],"annualized":[278],"bleed":[279],"rate":[280],"1.9":[282],"(mean":[283],"3.9,":[284],"range":[285],"0":[286],"42.1),":[288],"43":[290],"(45.7%)":[293],"experienced":[295],"no":[296,450],"bleeding":[297,303,444],"episodes.":[298,445],"187":[302],"episodes":[304],"30.6":[313],"IU/kg,":[314],"92.5%":[316],"resolved":[317],"1":[319],"or":[320,399],"2":[321],"infusions.":[322],"overall":[324],"adverse":[325],"event":[326],"(AE)":[327],"consistent":[330],"AE":[333,456],"products.":[340],"Two":[341],"transient,":[347],"low-titer,":[348],"clinically":[349],"silent":[350],"inhibitors":[351],"(0.98":[352],"BU/mL":[353],"1.21":[355],"BU/mL),":[356],"each":[357,367],"detected":[358],"by":[359],"surveillance":[361],"on":[362,370,418],"single":[364],"occasion":[365],"negative":[369,380],"testing.":[372],"corresponding":[374],"ELISAs":[375],"FVIII":[377,420],"antibodies":[378],"both":[382],"patients.":[383],"No":[384],"patient":[385],"study":[388],"positive":[391],"ELISA":[392],"immune":[393],"response":[394],"CHO":[396],"protein":[398],"used":[405],"purification.":[409],"pharmacokinetically":[413],"equivalent":[414],"activity":[421],"assessments,":[422],"stable":[428],"over":[429],"use.":[433],"product":[435],"effective":[437],"prevention":[440],"Inhibitor":[446],"results":[448],"show":[449],"evidence":[451],"neoantigenicity":[453],"demonstrates":[458],"hemophilia":[463],"A.":[464]},"counts_by_year":[{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-13T00:00:00"}